Nutex Health Inc. NUTX
220.11
15.52
7.59%
as of 25 Sep
- Market cap
- $1.4B
- P/E
- 8.4×
Follow NUTX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 70.50 | 70.50 | 70.50 | 70.50 | 70.50 | 0.00 | 0.00 | 3.19 | 17.38 |
P/S ratio |
— | 58.05 | 58.05 | 58.05 | 58.05 | 58.05 | 5.76 | 0.53 | 0.34 | 1.20 |
P/FCF ratio |
— | 144.46 | 144.46 | 144.46 | 144.46 | 144.46 | 35.12 | 0.00 | 7.74 | 4.26 |
P/Operating CF |
— | 663.75 | 663.75 | 663.75 | 663.75 | 663.75 | 280.38 | (74.48) | 2,987.55 | 14.88 |
P/B ratio |
— | 328.93 | 328.93 | 328.93 | 328.93 | 328.93 | 10.50 | 1.67 | 0.86 | 2.47 |
Price to Tangible BV |
— | 6,143.41 | 6,143.41 | 6,143.41 | 6,143.41 | 6,143.41 | 15.38 | 3.18 | 1.01 | 2.70 |
EV/Sales |
— | 58.03 | 58.03 | 58.03 | 58.03 | 58.03 | 6.71 | 1.47 | 0.87 | 1.33 |
EV/EBITDA |
— | 111.00 | 111.00 | 111.00 | 111.00 | 111.00 | 0.00 | 0.00 | 2.78 | 3.92 |
EV/Operating CF |
— | 113.07 | 113.07 | 113.07 | 113.07 | 113.07 | 29.07 | 290.08 | 18.04 | 4.68 |
EV/FCF |
— | 144.40 | 144.40 | 144.40 | 144.40 | 144.40 | 40.89 | (44.25) | 20.03 | 4.72 |
Quick Ratio |
0.00 | 0.02 | 0.29 | 0.25 | 0.04 | 4.00 | 1.69 | 1.45 | 1.81 | 3.24 |
Current Ratio |
0.08 | 0.06 | 0.29 | 0.27 | 0.14 | 4.09 | 1.79 | 1.56 | 1.90 | 3.41 |
Net Debt/EBITDA |
(0.09) | (0.06) | (1.15) | (0.19) | 0.00 | 0.67 | (0.53) | (16.39) | 1.71 | 0.43 |
Debt/Assets |
9.79% | 10.02% | 240.28% | 34.90% | 290.11% | 39.22% | 56.01% | 63.88% | 45.76% | 33.98% |
Debt/Equity |
(0.01) | 0.14 | (0.72) | 1.26 | (0.43) | 0.81 | 2.01 | 3.22 | 1.59 | 0.74 |
Asset Turnover |
0.00 | 0.01 | 0.72 | 0.38 | 79.86 | 1.68 | 0.53 | 0.60 | 0.91 | 1.11 |
Operating CF/Net income |
0.04 | (1.23) | 0.51 | 0.57 | 0.82 | 1.31 | (0.12) | (0.03) | 0.44 | 3.51 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.49) | (10.37) | (4.82) | (1.11) | (0.54) | (0.12) | (0.12) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | (33.26%) | (218.01%) | (3,942.66%) | 29,249.21% | 139.24% | (272.38%) | (45.92%) | 38.93% | 23.13% | |
| (2,910.02%) | 30.32% | (50.29%) | (199.29%) | 3,088.42% | 67.17% | (102.80%) | (11.03%) | 9.89% | 9.00% | |
ROIC |
0.00% | (132.11%) | 0.00% | (137.79%) | 0.00% | 34.30% | (77.50%) | (6.38%) | 18.36% | 31.34% |
Return on Tangible Assets |
126.59% | (64.61%) | 129.95% | 216.72% | (10,767.11%) | 49.43% | (339.27%) | (40.19%) | 24.10% | 14.89% |
Average Days of Receivables |
— | 99.12 | 49.72 | 26.77 | 0.02 | 126.34 | 97.06 | 92.52 | 179.52 | 135.71 |
Research and Development Expense of Revenue |
— | 110.34% | 39.88% | 56.21% | 0.20% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 7,817.24% | 84.46% | 310.66% | 1.62% | 1.65% | 9.12% | 14.56% | 12.18% | 19.27% |
Intangible Assets out of Total Assets |
0.00 | 0.98 | 0.00 | 0.75 | 0.00 | 0.00 | 0.09 | 0.09 | 0.04 | 0.04 |
Share Based Compensation of Revenue |
0.00% | 3,984.05% | 11.40% | 32.94% | 0.94% | 1.21% | 0.09% | 1.15% | 3.45% | 13.37% |
Graham Net Nets |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.17) | (1.73) | (1.08) | 0.04 |
Graham Number |
— | 5,026.86 | 497.27 | 0.00 | 0.00 | 215.56 | 0.00 | 0.00 | 91.01 | 119.09 |
Earnings Yield |
— | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | (33.05%) | (38.23%) | 31.37% | 5.75% |
Free Cash Flow Yield |
— | 0.69% | 0.69% | 0.69% | 0.69% | 0.69% | 2.85% | (6.23%) | 12.92% | 23.45% |
Revenue per Share |
0.00 | 21.09 | 119.91 | 56.46 | 69.31 | 83.85 | 51.81 | 56.18 | 94.28 | 137.59 |
Operating CF per Share |
(548.40) | (649.64) | (42.11) | (166.97) | 21.92 | 43.86 | 11.96 | 0.29 | 4.55 | 39.00 |
Capex per Share |
0.00 | 0.00 | 0.00 | (3.47) | (15.48) | (9.34) | (3.46) | (2.15) | (0.45) | (0.40) |
Free Cash Flow per Share |
(548.40) | (649.64) | (42.11) | (170.44) | 6.45 | 34.52 | 8.50 | (1.87) | 4.10 | 38.61 |
Cash per Share |
21.00 | 8.55 | 10.46 | 44.02 | 0.01 | 9.13 | 8.09 | 4.99 | 8.56 | 29.22 |
Shareholders Equity per Share |
(11,738.80) | 2,153.64 | (131.35) | 76.79 | (0.29) | 48.45 | 28.43 | 17.94 | 37.03 | 66.56 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(11,738.80) | 2,153.64 | (131.35) | 76.79 | (0.29) | 48.45 | 28.43 | 17.94 | 37.03 | 66.56 |
Free Cash Flow |
(0.27) | (0.71) | (0.48) | (4.12) | 25.48 | 136.51 | 35.97 | (8.24) | 20.85 | 245.60 |
Working Capital |
(5.87) | (0.90) | (0.74) | (3.37) | (1.00) | 116.32 | 43.11 | 32.54 | 138.25 | 380.90 |
Capital Expenditures |
— | — | — | (0.08) | (61.19) | (36.93) | (14.63) | (9.50) | (2.30) | (2.53) |
Net Current Asset Value |
(5.87) | (0.90) | (1.64) | (3.59) | (1.15) | (49.05) | (213.45) | (228.29) | (174.31) | 43.72 |
EV/EBIT |
— | 116.45 | 116.45 | 116.45 | 116.45 | 116.45 | 0.00 | 0.00 | 3.20 | 4.21 |
Capex to Sales |
— | 0.00 | 0.00 | 0.06 | 0.22 | 0.11 | 0.07 | 0.04 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 2,509.05% | (69.50%) | (520.82%) | 38.67% | 39.99% | (193.70%) | (18.49%) | 10.85% | 8.09% |
Price to Operating Income |
— | 116.49 | 116.49 | 116.49 | 116.49 | 116.49 | 0.00 | 0.00 | 1.23 | 3.80 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.42 | 140.79 | 0.42 | 2.06 | 475.68 | 0.05 | 0.16 | 0.22 | 0.25 | 0.22 |
Cash ROIC |
4.74% | (26.49%) | 163.46% | (78.41%) | (14,113.91%) | 5.63% | (7.94%) | (22.54%) | (10.30%) | 16.66% |
Accounts Receivable Turnover |
— | 0.00 | 14.20 | 9.54 | 4,624.96 | 5.78 | 2.53 | 4.09 | 3.21 | 3.12 |
Accounts Payable Turnover |
— | 0.09 | 1.11 | 0.72 | 95.11 | 16.60 | 9.02 | 8.06 | 15.89 | 14.51 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 107.17 | 64.24 | 61.49 | 90.92 | 150.80 |
Average Days of Payables |
0.00 | 4,169.38 | 407.71 | 770.39 | 2.18 | 42.32 | 49.29 | 43.35 | 13.41 | 41.47 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 11.87 | 0.00 | 6.75 | 6.33 | 5.81 | 3.67 | 2.43 |
Average Receivables |
— | — | 0.10 | 0.14 | 0.06 | 57.39 | 86.54 | 60.55 | 149.41 | 280.73 |
Average Payables |
— | 0.35 | 0.46 | 1.16 | 1.22 | 9.17 | 22.59 | 26.41 | 17.85 | 29.69 |
Average Inventory |
— | — | — | — | — | 1.42 | 3.17 | 3.46 | 3.12 | 2.86 |
Average Assets |
0.26 | 1.92 | 1.89 | 3.57 | 3.43 | 197.41 | 413.20 | 415.00 | 526.78 | 786.92 |
Average Common Equity |
— | (1.75) | 0.44 | 0.18 | 0.36 | 95.22 | 155.95 | 99.72 | 133.82 | 305.99 |
Columns are period end dates